'Still The Place To Do Drug Innovation': China Biotech CEO Podcast With InnoCare’s Jasmine Cui
R&D Speed, New Drug Coverage, Biogene, Incyte partnerships
From founding to the approval and commercial launch of its first innovative drug took Beijing-based biotech InnoCare just seven years. After a listing in Hong Kong, the firm is now heading to Shanghai after obtaining the green light for a second listing from the STAR board.
